Industry Comparables

OTC: CLCS

Stock Information

SHARE PRICE: $0.2961

VOLUME: 10,500

MARKET CAP: $13,909,830.00

SHARE COUNT: 43,468,200

DAILY HIGH: $0.3

DAILY LOW: $0.3

OPEN: $0.3

CLOSE: $0.3

PREV. CLOSE: $0.3

CHANGE: $0.0039 (-1.3000071%)

52-WEEK HIGH: $0.8401

52-WEEK LOW: $0.0002

LAST UPDATED: 9 hours ago

CompanySymbolMarketcapPriceExchangeChart (24H)
Cell Source, Inc.CLCS13.91M$0.2961OQB
CompanySymbolMarketcapPriceExchangeChart (24H)
Allogene Therapeutics, Inc.ALLO385.80M$1.84NMS
Atara Biotherapeutics, Inc.ATRA34.85M$6.05NMS
bluebird bio, Inc.BLUE79.14M$8.14NMS
Fate Therapeutics, Inc.FATE150.34M$1.32NGM
KDMN0.0000$0.0000
Legend Biotech CorporationLEGN6.36B$34.67NMS

Investor Presentation

Investor Relations Contact

Cell Source, Inc.
57 West 57th Street, Suite 400
New York, NY 10019

Phone: 646-612-7554
Toll Free: 888-315-4650
Email: info@cell-source.com

Securities Counsel

Giordano Halleran & Ciesla
Philip D. Forlenza, Esq.
125 Half Mile Road, Suite 300
Red Bank, NJ 07701-6777

Phone: 732-741-3900
Email: PForlenza@ghclaw.com
WWW: www.ghclaw.com

Independent Auditor

Marcum LLP
750 Third Ave, 11th Floor
New York, NY 10017

Additional Information

Subscribe to Cell Source’s Newsletter

    INVESTOR ALERTS. PRESS RELEASES. INDUSTRY & COMPANY NEWS.

    Get the latest Cell Source news and updates, delivered right to your inbox.